Patents Assigned to Genencor International, Inc.
  • Patent number: 7413877
    Abstract: The present invention provides compositions and methods related to the expression of Bowman-Birk protease inhibitors and variants thereof in bacterial species. The present invention further provides fusion nucleic acids, vectors, fusion polypeptides, and processes for obtaining the Bowman-Birk protease inhibitors.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: August 19, 2008
    Assignee: Genencor International, Inc.
    Inventors: Katherine Collier, Grant Ganshaw, Hans De Nobel, Scott D. Power, Anita Van Kimmenade, Marc Kolkman, Jeffrey Miller, Brian Schmidt, Gudrun Vogtentanz, David Estell
  • Patent number: 7407780
    Abstract: The invention provides methods for producing products comprising improved host cells genetically engineered to have uncoupled productive and catabolic pathways. In particular, the present invention provides host cells having a modification in nucleic acid encoding an endogenous enzymatic activity that phosphorylates D-glucose at its 6th carbon and/or a modification of nucleic acid encoding an enzymatic activity that phosphorylates D-gluconate at its 6th carbon. Such improved host cells are used for the production of products, such as, ascorbic acid intermediates. Methods for making and using the improved host cells are provided. Nucleic acid and amino acid sequences for glucokinase and gluconokinase are provided.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: August 5, 2008
    Assignee: Genencor International, Inc.
    Inventors: Timothy C. Dodge, Fernando Valle
  • Patent number: 7407791
    Abstract: Described herein are methods and compositions for the production and secretion of polypeptides. Included herein is the use of interrupting peptide transport activity for an increase in polypeptide production and/or secretion.
    Type: Grant
    Filed: August 6, 2003
    Date of Patent: August 5, 2008
    Assignee: Genencor International, Inc.
    Inventor: Maria R. Diaz-Torres
  • Publication number: 20080182971
    Abstract: Methods for forming peptide derivatives using functional moieties and peptide derivatives are provided. Further, methods for using peptide derivatives to form silicon-based composite materials and silicon-based composite materials formed thereby are provided. The silicon-based composite materials may have features on the nanoscale, and the materials may exhibit characteristics derived from the functional moieties on the peptide derivatives. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that is will not be used to interpret or limit the scope or meaning of the claims. 37 CFR 1.72(b).
    Type: Application
    Filed: October 22, 2007
    Publication date: July 31, 2008
    Applicant: GENENCOR INTERNATIONAL, INC.
    Inventors: Joseph C. McAuliffe, Risha Lindig Bond, William Albert Cuevas
  • Patent number: 7402664
    Abstract: The present application relates to peptides which bind to a target stain, phenol oxidizing enzyme-binding peptide complexes wherein the binding peptide is attached to the C-terminus of the phenol oxidizing enzyme or is inserted or substituted into the phenol oxidizing enzyme. In a preferred embodiment the phenol oxidizing enzyme is a laccase specifically Stachybotrys oxidase B and variants thereof. The invention provides expression vectors comprising the phenol oxidizing enzyme-binding peptide complex as well as host cells comprising the vectors.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: July 22, 2008
    Assignee: Genencor International, Inc.
    Inventors: Aehle Wolfgang, Toby M. Baldwin, Franciscus J. C. van Gastel, Giselle G. Janssen, Christopher J. Murray, Huaming Wang, Deborah S. Winetzky
  • Patent number: 7399623
    Abstract: The present invention relates to modified pullulanases useful in the starch industry. The present invention provides methods for producing the modified pullulanase, enzymatic compositions comprising the modified pullulanase, and methods for the saccharification of starch comprising the use of the enzymatic compositions.
    Type: Grant
    Filed: September 16, 2002
    Date of Patent: July 15, 2008
    Assignee: Genencor International, Inc.
    Inventors: Brian S. Miller, Jayarama K. Shetty
  • Patent number: 7396688
    Abstract: The present invention makes use of unique tags of a specific biopolymer that can be exploited for determining the concentration the biopolymer in crude solutions. In preferred embodiments the biopolymer is either a protein or a polynucleotide. Particularly, the invention provides a method for the determination and quantitation of biomolecules in crude mixtures by way of a separation technique in combination with mass spectroscopy. In one general embodiment, a target biomolecule is selected for analysis and an analog thereof is generated. Peak area integration of the peptide pairs provides a direct measure for the amount of target protein in the crude solution.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: July 8, 2008
    Assignee: Genencor International, Inc.
    Inventors: David A. Estell, Grant C. Ganshaw, Christian Paech, Sigrid Paech
  • Patent number: 7381789
    Abstract: Methods for forming repeat protein polymers and utilizing the repeat protein polymers to form inorganic structures are provided. The inorganic structures may have features on the nanoscale, and the structures generally do not have the repeat protein polymer incorporated therein.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: June 3, 2008
    Assignee: Genencor International, Inc.
    Inventor: Manoj Kumar
  • Patent number: 7381830
    Abstract: The present invention is related to cis-diols and biological methods of producing cis-diols. The present invention further relates to processes for subsequently converting such silane cis-diols to the more stable acetonide derivatives, as well as a process for converting silane cis-diols to the corresponding catechols and the compounds produced thereby. The present invention also provides chemical methods for the conversion of said silane cis-diols and acetonide compounds to epoxy, saturated and otherwise modified derivatives. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that is will not be used to interpret or limit the scope or meaning of the claims.
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: June 3, 2008
    Assignee: Genencor International, Inc.
    Inventors: Joseph C. McAuliffe, Gregory M. Whited, Wyatt Charles Smith
  • Patent number: 7381812
    Abstract: Described herein are methods for the enhanced production of secreted proteins. The secretion of a protein of interest having a substantially non-polar carboxy tail is enhanced by the placement of charged amino acid residues at the carboxy terminus either by adding to the native peptide or by replacing, i.e., substituting, the terminal residues of the native peptide.
    Type: Grant
    Filed: August 26, 2004
    Date of Patent: June 3, 2008
    Assignee: Genencor International, Inc.
    Inventor: Marc Kolkman
  • Patent number: 7378219
    Abstract: The present invention relates to materials comprising hydrophilic polymers and immobilized proteorhodopsin and the use of such materials as an optical information carrier. The material comprises one or more hydrophilic polymers that are capable to form a homogeneous phase with proteorhodopsin prior to solidification to a solid form. The hydrophilic polymer, for example, is silica sol-gel, gelatin, polyvinylalcohol, agarose, agar, methyl cellulose, polyvinyl acetate, polyvinyl pyrrolidone, polyethylene glycol, or a mixture thereof. The solid material having immobilized proteorhodopsin is deposited on a substrate selected from the group consisting of glass, paper, metal, fabric material, plastic material, and used as an optical data storage material or a fraud-proof carrier. The present invention further provides a security ink comprising proteorhodopsin and one or more hydrophilic polymers.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: May 27, 2008
    Assignee: Genencor International, Inc.
    Inventors: Rasmus B. Jensen, Bradley R. Kelemen, Joseph C. McAuliffe, Wyatt Charles Smith
  • Patent number: 7378256
    Abstract: The present invention relates to isolated promoter sequences, particularly a promoter isolated from Aspergillus niger designated herein as A4-L or A4 and DNA constructs and vectors including the same.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: May 27, 2008
    Assignee: Genencor International, Inc.
    Inventors: Steve Kim, Edwin Lee, Wei Liu, Huaming Wang
  • Patent number: 7374684
    Abstract: The present invention provides methods for separating one or more components of interest from a sample containing particulates and soluble materials. The method comprises the steps of: (a) filtering a sample through silica filter media whose surface silanol groups have reacted with one or more silanes, and (b) simultaneously capturing particulates and binding a soluble component to the silica filter media. The bound soluble component of interest is subsequently eluted from the silica filter media. In one embodiment of the invention, unwanted soluble materials are captured by the treated silica filter media and desired component of interest is recovered from the flow-through. In another embodiment, different components of interest are recovered from both the eluate and the flow-through. Preferred treated silica filter media are silane-treated rice hull ash or diatomaceous earth with functional quarternary ammonium group or functional sulphonate group.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: May 20, 2008
    Assignees: Dow Corning Corporation, Genencor International, Inc.
    Inventors: Gary L. Gibson, Keith Hayes, Meng H. Heng, Csilla Kollar, Thomas H. Lane, Anthony Revis, Landon M. Steele
  • Patent number: 7374917
    Abstract: Described herein are novel nucleic acids, proteins and methods that can be used to provide new catalysts with desirable traits for industrial processes. In particular, novel reductases isolated from the environment using PCR methods are described.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: May 20, 2008
    Assignee: Genencor International, Inc.
    Inventors: Mark Donnelly, William H. Eschenfeldt, Jonathan Trent
  • Patent number: 7371553
    Abstract: This invention provides modified enzymes comprising one or more amino acid residues replaced by cysteine residues, where the cysteine residues are modified by replacing the thiol hydrogen in the cysteine residues with a substituent group providing a thiol side chain comprising a multiply charged moiety. The enzymes show improved interaction and/or specificity and/or activity with charged substrates.
    Type: Grant
    Filed: November 19, 2004
    Date of Patent: May 13, 2008
    Assignees: Genencor International, Inc., The Governing Council of the University of Toronto
    Inventors: Benjamin G. Davis, John Bryan Jones, Richard R. Bott
  • Patent number: 7371585
    Abstract: The present invention provides a thiosulfonate-activated ionophore comprising an ionophore, a spacer group, and an alkylthiosulfonate moiety. A preferred ionophore is gramicidin A. A preferred alkylthiosulfonate is methanethiosulfonate. The present invention also provides a conjugate comprising an ionophore, a spacer group, and a recognition molecule. Further the invention related to membranes incorporating the conjugates and biosensors comprising said membranes.
    Type: Grant
    Filed: December 28, 2004
    Date of Patent: May 13, 2008
    Assignee: Genencor International, Inc.
    Inventor: Rafael Fernando Sala
  • Patent number: 7361731
    Abstract: Methods for forming peptide derivatives using functional moieties and peptide derivatives are provided. Further, methods for using peptide derivatives to form silicon-based composite materials and silicon-based composite materials formed thereby are provided. The silicon-based composite materials may have features on the nanoscale, and the materials may exhibit characteristics derived from the functional moieties on the peptide derivatives. It is emphasized that this abstract is provided to comply with the rules requiring an abstract which will allow a searcher or other reader to quickly ascertain the subject matter of the technical disclosure. It is submitted with the understanding that is will not be used to interpret or limit the scope or meaning of the claims.
    Type: Grant
    Filed: May 20, 2003
    Date of Patent: April 22, 2008
    Assignee: Genencor International, Inc.
    Inventors: Joseph C. McAuliffe, Risha Lindig Bond, William Albert Cuevas
  • Patent number: 7354752
    Abstract: The present invention relates to an acid-stable alpha amylase (asAA) derived from a strain of Aspergillus kawachi, which has granular starch hydrolyzing (GSH) activity, the heterologous expression of the asAA having GSH activity in filamentous fungal host cells and enzyme compositions including the same which optionally include glucoamylase.
    Type: Grant
    Filed: May 24, 2005
    Date of Patent: April 8, 2008
    Assignee: Genencor International, Inc.
    Inventors: Nigel Dunn-Coleman, Susan M. Fiske, Suzanne E. Lantz, Paulien Neefe-Kruithof, Michael J. Pepsin, Jayarama K. Shetty
  • Patent number: 7351568
    Abstract: The present invention provides a novel endoglucanase nucleic acid sequence, designated egl6, and the corresponding EGVI amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVI, recombinant EGVI proteins and methods for producing the same.
    Type: Grant
    Filed: January 10, 2006
    Date of Patent: April 1, 2008
    Assignee: Genencor International, Inc.
    Inventors: Nigel Dunn-Coleman, Frits Goedegebuur, Michael Ward, Jian Yao
  • Patent number: 7351573
    Abstract: The present invention provides a novel ?-glucosidase nucleic acid sequence, designated bgl3, and the corresponding BGL3 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL3, recombinant BGL3 proteins and methods for producing the same.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: April 1, 2008
    Assignee: Genencor International, Inc.
    Inventors: Nigel Dunn-Coleman, Frits Goedegebuur, Michael Ward, Jian Yao